Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
NCT04479696 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117
Last updated 2026-01-20
Summary
This trial studies whether a customized video intervention can help to reduce anxiety in brain cancer patients undergoing radiation treatment and their caregivers. A customized neuro-imaging referenced symptom video that describes symptoms and side effects specific to the patients' tumor may result in an early and sustained reduction in anxiety and distress during and after radiation treatment, thereby improving quality of life.
Conditions
- Glioblastoma
- WHO Grade II Glioma
- WHO Grade III Glioma
Interventions
- OTHER
-
Educational Intervention
Receive standard of care verbal and written education materials
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Survey Administration
Complete optional survey
- OTHER
-
Video
Watch NIRS video
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Caroline Chung · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-05
- Primary Completion
- 2026-06-01
- Completion
- 2026-06-01
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00003996 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
NCT00002569 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
NCT00492687 ·Status: UNKNOWN ·Phase: PHASE2
-
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
NCT02360215 ·Status: COMPLETED ·Phase: PHASE3
-
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
NCT02696993 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
NCT00003309 ·Status: COMPLETED ·Phase: PHASE2
-
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
NCT00114140 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
NCT00276640 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
NCT00005637 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
NCT00007007 ·Status: COMPLETED ·Phase: NA
-
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
NCT00566852 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
NCT00005602 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy
NCT02698254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
NCT00006916 ·Status: TERMINATED ·Phase: PHASE2
-
Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
NCT00820963 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
NCT02709226 ·Status: COMPLETED ·Phase: PHASE1
-
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
NCT01062425 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
NCT00002806 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor
NCT00085098 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00482677 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
NCT00626730 ·Status: UNKNOWN ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Glioblastoma
NCT00019058 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
NCT00978458 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00099125 ·Status: COMPLETED ·Phase: PHASE2
-
Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
NCT00469937 ·Status: TERMINATED ·Phase: PHASE1